Press Room
Register
Subscribe

Contact Us

For submission information contact Susan Holtzman at
abstracts@vivaphysicians.org

For more information on the VIVA Symposium or Late Breaking Clinical Trials, contact:

Susan O. Holtzman
305-975-5293
press@vivaphysicians.org

More »

Presentation Schedule

Late-Breaking Clinical Trials will be presented daily at VIVA 16 in the General Session beginning on Monday, September 19, 2016. To register to attend VIVA 16, please click Register button on the left sidebar.

Monday, September 19, 2016

Time Trial Name Presenter
8:31 AM MOBILE Clinical Trial:  MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects with Severe Peripheral ArteriaL DiseasE (PAD) Michael P. Murphy, MD, FACSM_Murphy_LBCT
8:43 AM Safety and Performance of the Shockwave Lithoplasty® System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-phase DISRUPT PAD Study. Thomas Zeller, MD
T_Zeller_LBCT
8:55 AM Results from the IN.PACT SFA Randomized Trial Prakash Krishnan, MD
PKrishnan_LBCT
9:07 AM VIRTUS US Iliofemoral Stenting IDE Trial Stephen Black, MD
SteveBlack_LBCT
9:19 AM Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort Michael R. Jaff, DO
Jaff_LBCT

Tuesday, September 20, 2016

Time Trial Name Presenter
8:10 AM Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study Ali Azizzadeh, MD
A_Azizzadeh_LBCT
8:22 AM Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry Zvonimir Krajcer, MD
ZKrajcer_LBCT
8:34 AM Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach Charmaine Lok, MD, FRCPCLok_Charmaine_LBCT
8:46 AM MAJESTIC 2 Year Results Plus Sub-group Analysis Stefan Müller-Hülsbeck, MDHulsbeck_LBCT
8:58 AM 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study Antonio Micari, MD
A_Micari_LBCT

Wednesday, September 21, 2016

Time Trial Name Presenter
9:10 AM

ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial
Femoral (SFA) or Common or External Iliac Arteries

Michael R. Jaff, DO
Jaff_LBCT
9:22 AM 12 Month Results from the DANCE Trial Atherectomy Cohort Chris Owens, MD
C_OwensLBCT
9:34 AM Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial John Laird Jr., MD
J_Laird_LBCT
9:44 AM Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial Ido Weinberg, MD
I_Weinberg_LBCT
9:54 AM Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial John Laird Jr., MD
J_Laird_LBCT
10:04 AM PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery Richard Saxon, MD
R_Saxon_LBCT